TSW
ASTX

Thompson Siegel & Walmsley’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,200
Closed -$53K – 691
2013
Q3 		$53K Hold
6,200
– – ﹤0.01% 455
2013
Q2 		$25K Buy
+6,200
New +$33.3K ﹤0.01% 513

Thompson Siegel & Walmsley's ASTX Position: Q4 2013 in Review

Thompson Siegel & Walmsley sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 6,200 shares — an estimated $53K sold.

Thompson Siegel & Walmsley first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $53K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Thompson Siegel & Walmsley reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 6,200 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $53K.
  • Thompson Siegel & Walmsley first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Thompson Siegel & Walmsley's ASTEX PHARMACEUTICALS, INC COM position peaked at $53K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2013, filed 6 Feb 2014.